Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives

由 Jenke, Robert, Reßing, Nina, Hansen, Finn K., Aigner, Achim, Büch, Thomas
發表在 Cancers (Basel) (2021)

Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity

由 Reßing, Nina, Marquardt, Viktoria, Gertzen, Christoph G. W., Schöler, Andrea, Schramm, Alexander, Kurz, Thomas, Gohlke, Holger, Aigner, Achim, Remke, Marc, Hansen, Finn K.
發表在 Medchemcomm (2018)

Discovery of the first-in-class dual histone deacetylase-proteasome inhibitor

由 Bhatia, Sanil, Krieger, Viktoria, Groll, Michael, Osko, Jeremy D., Reßing, Nina, Ahlert, Heinz, Borkhardt, Arndt, Kurz, Thomas, Christianson, David W., Hauer, Julia, Hansen, Finn K.
發表在 J Med Chem (2018)

Multicomponent synthesis, binding mode and structure-activity relationships of selective histone deacetylase 6 (HDAC6) inhibitors with bifurcated capping groups

由 Reßing, Nina, Sönnichsen, Melf, Osko, Jeremy D., Schöler, Andrea, Schliehe-Diecks, Julian, Skerhut, Alexander, Borkhardt, Arndt, Hauer, Julia, Kassack, Matthias U., Christianson, David. W., Bhatia, Sanil, Hansen, Finn K.
發表在 J Med Chem (2020)